Aug 09, 2021 / 12:30PM GMT
Operator
Good morning, everyone. My name is Keith, and I'll be your conference operator today. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Second Quarter 2021 Financial Results Call. (Operator Instructions) As a reminder, this conference call is being recorded today, August 9, 2021. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead.
Lisa Wilson - Eagle Pharmaceuticals, Inc. - IR, In-Site Communications, Inc.
Thank you, Keith. Welcome to Eagle Pharmaceuticals' Second Quarter Earnings call. This is Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. With me on today's call are Eagle's Chief Executive Officer, Scott Tarriff; Chief Medical Officer, Dr. Judith Ng-Cashin; and Chief Financial Officer, Brian Cahill. This morning, the company issued a press release detailing financial results for the 3 months ended June 30, 2021. This press release and a webcast of this call can be accessed through the Investors section of the Eagle website at eagleus.com.
Before
Q2 2021 Eagle Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot